Increasing Vaccine Uptake in Underresourced Public Housing Areas

Sponsor
Charles Drew University of Medicine and Science (Other)
Overall Status
Recruiting
CT.gov ID
NCT04779138
Collaborator
(none)
600
1
1
26.6
22.5

Study Details

Study Description

Brief Summary

This proposal seeks to enhance uptake and completion of COVID-19 vaccination among African American and Latinx public housing residents in South Los Angeles. Given the multiple disparities experienced by public housing residents, the investigators will utilize a theoretically-based, multidisciplinary and culturally tailored intervention to provide education at multiple levels and implement innovate strategies to engage this population in the uptake of COVID-19 vaccination.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Increasing Willingness and Uptake of COVID-19 Vaccination
N/A

Detailed Description

One particular group, African American and Latinx public housing residents, are facing adverse effects related to worsening social determinants and health disparities. Utilizing a community-driven approach, the overall objective of this proposed study is to increase COVID-19 vaccine uptake and completion the impact of COVID-19 among African American and Latinx public housing residents. Guided by the Community Based Participatory Model, the Information, Motivation, and Behavioral Skills (IMB) and the Transtheoretical Model will be utilized to carry out this intervention. Through this innovative program, we will establish Academic-Community Team for Improving Vaccine Acceptability and Targeted Engagement (ACTIVATE) program, which will develop leadership triads of public housing resident leaders, nurse practitioner students, and public health students to carry out this multilevel intervention.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
600 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Community Partnered Intervention to Increase COVID-19 Vaccine Uptake in Low Income Underresourced African Americans and Latinx Public Housing Residents
Actual Study Start Date :
Sep 11, 2021
Anticipated Primary Completion Date :
Oct 31, 2023
Anticipated Study Completion Date :
Nov 30, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Increasing Uptake of COVID-19 Vaccination

This is a pre-experimental "one group pretest-posttest" design to increase COVID-19 vaccine uptake and completion among African American and Latinx public housing residents in South Los Angeles. The proposed intervention will employ (1) culturally sensitive, (2) theoretically based intervention that will be jointly delivered by our ACTIVATE triad leaders and our researchers. We will use the Information, Motivation, and Behavioral Skills (IMB) model and the Transtheoretical Model to implement the intervention.

Behavioral: Increasing Willingness and Uptake of COVID-19 Vaccination
Provide/enhance knowledge, modify attitudes, motivate and provide skills and resources to reduce COVID-19 vaccine hesitancy and increase willingness and uptake in COVID-19 vaccination.

Outcome Measures

Primary Outcome Measures

  1. Prevalence of vaccination uptake for COVID-19, influenza, and pneumonia using Vaccination History Self Report [Intervention: 4 months; Follow-up Point: 3 months post-intervention]

    1. By comparison of pre-, post- intervention, and 9- and 18-months follow-up data, we anticipate the following compared to baseline: a 40% change in completion of COVID-19 vaccination series

Secondary Outcome Measures

  1. Percentage of Participants Achieving Decreased Vaccine Hesitancy Levels of COVID-19 vaccine Using the NIH Toolbox Surveys on COVID-19 [Intervention: 4 months; Follow-up Point: 3 months post-intervention]

    1. By comparison of pre-, post- intervention, and 3-months follow-up data, we anticipate the following compared to baseline: a 40% change in hesitancy toward COVID-19 vaccination.

  2. Percentage of Participants Achieving Increased Level of Behavior Change toward COVID-19 Vaccination Using the NIH Toolbox Surveys on COVID-19 [Intervention: 4 months; Follow-up Point: 3 months post-intervention]

    2. By comparison of pre-, post- intervention, and 3-months follow-up data, we anticipate the following compared to baseline: a 40% change in their behavior stage of change toward COVID-19 vaccination

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Aim 2:
Inclusion Criteria:
  • identify as Latinx or African American

  • age 18 or older

  • reside in one of the six collaborating public housing area

  • Speak either English or Spanish

Exclusion Criteria:
  • Not a resident at one of the collaborating public housing areas

  • Does not self-identify as African American or Latinx

  • Age 17 and younger

  • Unable to speak either English or Spanish

Aim 3:
Inclusion Criteria:
  • identify as Latinx or African American

  • age 18 or older

  • reside in one of the six collaborating public housing area

  • Speak either English or Spanish

  • Report vaccine hesitancy

Exclusion Criteria:
  • Not a resident at one of the collaborating public housing areas

  • Does not self-identify as African American or Latinx

  • Age 17 and younger

  • Unable to speak either English or Spanish

  • Received all recommended vaccines for COVID-19

  • No reporting of vaccine hesitancy

Contacts and Locations

Locations

Site City State Country Postal Code
1 Charles R. Drew University of Medicine & Science Los Angeles California United States 90059

Sponsors and Collaborators

  • Charles Drew University of Medicine and Science

Investigators

  • Principal Investigator: Sharon Cobb, Charles R. Drew University of Medicine & Science

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Charles Drew University of Medicine and Science
ClinicalTrials.gov Identifier:
NCT04779138
Other Study ID Numbers:
  • vaccinehousing
First Posted:
Mar 3, 2021
Last Update Posted:
Feb 1, 2022
Last Verified:
Jan 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 1, 2022